Delivery Order SPE2DB24D2100-SPE2DB25FBDZN
Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,859.42 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. This firm fixed-price, non-competitive set-aside contract was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same city....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to provide Meloxicam 7.5 mg tablets. The $27,398.90 contract has a performance period through March 14, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 with a period of performance through...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.47 to AmerisourceBergen Drug Corp for 90 tablets of Meloxicam 15 mg, with a completion date of February 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Meloxicam 15 mg tablets in a 90-count package, with a contract value of $2,000.95 and completion targeted for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 15 mg meloxicam tablets. The order, valued at $7,916.30, is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a maximum value of $999,999,999 through December 2025. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and...
- This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meloxicam 15 mg tablet units (100 count) valued at $1,149.80 on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Meloxicam is a nonsteroidal anti-inflammatory drug commonly used in military and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $39,727.67 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract was issued on August 2, 2025, with an ultimate completion date of the same day, indicating a rapid fulfillment requirement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,200.54 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies and pharmaceuticals needed to support federal healthcare operations. The order will be performed at AmerisourceBergen's...